quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:03·105d
SECFiling
Mersana Therapeutics Inc. logo

SEC Form EFFECT filed by Mersana Therapeutics Inc.

MRSN· Mersana Therapeutics Inc.
Health Care
Original source

Companies

  • MRSN
    Mersana Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Feb 6UpdateWilliam Blair-
  • Nov 15UpdateCitigroup$5.00
  • Mar 19UpdateJP Morgan$5.00
  • Feb 29UpdateBTIG Research$6.00
  • Feb 29UpdateGuggenheim$7.00
  • Feb 29UpdateWedbush$7.00

Related

  • SEC97d
    SEC Form 15-12G filed by Mersana Therapeutics Inc.
  • INSIDER107d
    Director Hack Andrew A. F. closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    Director Hege Kristen closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    Director Diaz Allene M. closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    Director Dere Willard H closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    SVP, Chief Legal Officer Carvajal Alejandra closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    SVP, Chief Development Bala Mohan closing all direct ownership in the company (SEC Form 4)
  • INSIDER107d
    Director Alleva Lawrence M closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022